SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India informs about investor meeting

28 Mar 2020 Evaluate

Pursuant to provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Granules India has informed about the scheduled of  Investor meeting as on 28th March 2020 with ICIC Venture, details of the same as enclosed.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

685.00 -1.75 (-0.25%)
24-Apr-2026 15:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.50
Dr. Reddys Lab 1315.50
Cipla 1295.85
Zydus Lifesciences 926.65
Lupin 2295.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×